Target intelligence / Profile preview

D-Alanyl-D-alanine terminus of cell wall peptidoglycan

Molecular classification
Other
01

Overview

The D-Alanyl-D-alanine terminus of cell wall peptidoglycan is a short peptide sequence (D-Ala-D-Ala) found at the end of the stem peptides within nascent bacterial peptidoglycan precursors, especially abundant in Gram-positive bacteria. It is critical for the final cross-linking (transpeptidation) reactions that provide bacterial cell wall rigidity and structural integrity[1][3][7]. This motif is the direct binding site for glycopeptide antibiotics such as vancomycin, which block the cross-linking of new cell wall subunits by capping this dipeptide and thereby halting cell wall biosynthesis, leading to bacteriolysis. Resistance can develop by alteration of this terminus, such as replacing the terminal D-Ala with D-lactate (D-Ala-D-Lac), reducing drug efficacy[6]. Targeting this motif underpins the mechanism of action for a major class of antibiotics used in serious infections due to Gram-positive bacteria.

Other names
D-Ala-D-Ala terminusD-Alanyl-D-alanine terminusPeptidoglycan D-Ala-D-Ala terminusTerminal D-alanine dipeptide
02

Mechanism of action

Inhibition of cell wall synthesis by sterically blocking transpeptidase (DD-transpeptidase) cross-linking at the D-Ala-D-Ala terminus Direct binding by glycopeptide antibiotics prevents addition of new peptidoglycan subunits

03

Biological functions

Cell wall biosynthesisOsmotic protectionMaintenance of cell shape
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistance (e.g., vancomycin-resistant enterococci, VRE) via alteration of this terminusPotential nephrotoxicity and ototoxicity with glycopeptide drugs
06

Interacting drugs

Vancomycin

5 more in the full profile.

07

Biomarkers

Presence of vancomycin susceptibility/resistance genes (e.g., vanA/vanB, which alter the D-Ala-D-Ala motif to D-Ala-D-Lac or D-Ala-D-Ser) in pathogens

Beyond the preview

Go deeper on D-Alanyl-D-alanine terminus of cell wall peptidoglycan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-Alanyl-D-alanine terminus of cell wall peptidoglycan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call